Brain Tumor Support Group Open House And Treatment Options Update

July 30, 1998

Cedars-Sinai Medical Center's Neurosurgical Institute will host a Brain Tumor Support Group Open House for patients and families on Wednesday, August 5, from 6-9 p.m. Members of the news media are invited to attend. World-renowned brain surgeon Keith L. Black, M.D., and other Neurosurgical Institute physicians will be available for interviews (must be arranged in advance by calling 1-800-396-1002).

The Brain Tumor Support Group Open House will feature educational lectures, screenings for depression and anxiety, and a preview of new support groups that will be facilitated by Cedars-Sinai psychologists and Wellness Community counselors. The event will launch a monthly series of programs that will combine updates on the latest medical advances in brain tumor research and treatments, as well as psychological support groups for patients and their loved ones.

When: Wednesday, Aug. 5, from 6 to 9 p.m.

Where: Cedars-Sinai Medical Center, Harvey Morse Auditorium, 8700 Beverly Blvd., Los Angeles, Calif.

Why: The physical and psychological challenges confronting brain tumor patients and their families and friends can be overwhelming. This program will offer an update on the latest in treatment options by Neurosurgical Institute physicians, including radiation, chemotherapy, and future strategies using gene therapy and immunology. Panel discussions also will explore the psychological journeys facing patients and their families and friends.For a schedule of speakers, or to arrange an interview with Dr. Black and his colleagues or patients, call 1-800-396-1002.

Cedars-Sinai Medical Center

Related Chemotherapy Articles from Brightsurf:

Chemotherapy is used to treat less than 25% of people with localized sarcoma
UCLA researchers have found that chemotherapy is not commonly used when treating adults with localized sarcoma, a rare type of cancer of the soft tissues or bone.

Starved cancer cells became more sensitive to chemotherapy
By preventing sugar uptake, researchers succeeded in increasing the cancer cells' sensitivity to chemotherapeutic treatment.

Vitamin D could help mitigate chemotherapy side effects
New findings by University of South Australia researchers reveal that Vitamin D could potentially mitigate chemotherapy-induced gastrointestinal mucositis and provide relief to cancer patients.

Less chemotherapy may have more benefit in rectal cancer
GI Cancers Symposium: Colorado study of 48 patients with locally advanced rectal cancer receiving neoadjuvant chemotherapy, found that patients receiving lower-than-recommended doses in fact saw their tumors shrink more than patients receiving the full dose.

Male fertility after chemotherapy: New questions raised
Professor Delb├Ęs, who specializes in reproductive toxicology, conducted a pilot study in collaboration with oncologists and fertility specialists from the McGill University Health Centre (MUHC) on a cohort of 13 patients, all survivors of pediatric leukemia and lymphoma.

'Combo' nanoplatforms for chemotherapy
In a paper to be published in the forthcoming issue in NANO, researchers from Harbin Institute of Technology, China have systematically discussed the recent progresses, current challenges and future perspectives of smart graphene-based nanoplatforms for synergistic tumor therapy and bio-imaging.

Nanotechnology improves chemotherapy delivery
Michigan State University scientists have invented a new way to monitor chemotherapy concentrations, which is more effective in keeping patients' treatments within the crucial therapeutic window.

Novel anti-cancer nanomedicine for efficient chemotherapy
Researchers have developed a new anti-cancer nanomedicine for targeted cancer chemotherapy.

Ending needless chemotherapy for breast cancer
A diagnostic test developed at The University of Queensland might soon determine if a breast cancer patient requires chemotherapy or would receive no benefit from this gruelling treatment.

A homing beacon for chemotherapy drugs
Killing tumor cells while sparing their normal counterparts is a central challenge of cancer chemotherapy.

Read More: Chemotherapy News and Chemotherapy Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to